Name: CAPITELLO-281
What type of cancer is this for? Prostate
Phase: III
Who is this trial for? Men who have hormone sensitive prostate cancer (testosterone can be stopped or blocked to help prevent cancer growth) that has spread to other parts of the body.
What is National Clinical Trial #? : NCT04493853
Brief summary of trial: This trial is looking to see how well capivasertib and abiraterone work compared to a harmless medicine and abiraterone.
Need to know: Your tumor tissue must be PTEN negative. (PTEN stands for Phosphatase and TENsin homolog deleted on chromosome 10)
Where is this trial available? The Cancer & Hematology Centers
For more information, please call 616-975-3065 or email clinicaltrials@chcwm.com
NAME: PanTumor 3- PROSTATE
What type of cancer is this for? Prostate
Phase: II
Who is this trial for? Men with advanced prostate cancer that may have spread to other parts of your body.
What biomarkers are involved? None
What is National Clinical Trial #? NCT05489211
Brief summary of trial: This trial is looking to see what drug combination works better to treat your prostate cancer.
Need to know: Your prostate cancer must be “castration-resistant”, which means that your cancer continues to grow even when your testosterone level is very low.
Where is this trial available? The Cancer & Hematology Centers
For more information, please call 616-975-3065 or email clinicaltrials@chcwm.com